NABRIVA THERAPEUTICS PLC (NBRV)

Arbutus Appoints Two New Executives

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

7 Stocks to Sell as Banks Melt Down

Although the internet encourages you to buy the red ink, sometimes you should consider stocks to sell as just that.

NBRV stock on watch as Merck ends distribution agreement (NASDAQ:NBRV)

Nabriva Therapeutics (NBRV) and Merck (MRK) have ended the deal for U.S. distribution of Sivextro, an antibacterial indicated for certain skin and skin infections. Read the full story here.

Nabriva Therapeutics Provides Corporate Update

-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- ...

NBRV stock gains after announcing Phase 1 data for cystic fibrosis candidate (NASDAQ:NBRV)

Ireland-based pharma Nabriva Therapeutics (NBRV) rose ~15% on Monday morning after announcing results from a Phase 1 trial for its antibiotic Xenleta in adults with cystic...

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with...

Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update

- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya...

Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

Rigetti (RGTI) Stock Pops on New Quantum Computing Partners

Rigetti (RGTI) stock is getting a boost on Friday after the company revealed it found new partners for its quantum computing efforts.

Why Is Esports Entertainment (GMBL) Stock Down 45% Today?

Esports Entertainment (GMBL) stock is falling hard on Friday after the company revealed the pricing of a public stock offering.

What Is Going on With Nabriva Therapeutics (NBRV) Stock Today?

Nabriva Therapeutics (NBRV) stock caught the attention of traders on Friday after shares surged in price early this morning.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them!

Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split

DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) --  Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis

- Topline Data Expected First Quarter 2023 -...

Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

-Net Product Sales of $8.7M Grew 25% versus Q2 2021- -SIVEXTRO Prescription Demand Grew 28% versus Q2 2021- -Conference Call Today at 4:30 p.m. Eastern...

Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022

DUBLIN, Ireland and FORT WASHINGTON, Pa., July 20, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals

DUBLIN, Ireland and FORT WASHINGTON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!